Trafficking of QD‐Conjugated MPO‐ANCA in Murine Systemic Vasculitis and Glomerulonephritis Model Mice
暂无分享,去创建一个
Hiroshi Hashimoto | Masato Yasuhara | Akiyoshi Hoshino | Kazuo Suzuki | Kenji Yamamoto | Kazuo Suzuki | H. Hashimoto | N. Ohno | A. Hoshino | M. Yasuhara | Kenji Yamamoto | K. Uno | T. Nagao | Tomokazu Nagao | Toshiko Ito-Ihara | Akiko Ishida-Okawara | Kazuko Uno | Eri Muso | Noriko Nagi-Miura | Naohito Ohno | Kazuhiro Tokunaka | Shiro Naoe | E. Muso | T. Ito-Ihara | A. Ishida-Okawara | K. Tokunaka | S. Naoe | Noriko Nagi‐Miura | A. Ishida‐Okawara
[1] M. Zenke,et al. Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils. , 2005, Journal of the American Society of Nephrology : JASN.
[2] J. Pearson,et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. , 1992, The American journal of pathology.
[3] Kazuo Suzuki,et al. Contribution of peroxidases in host-defense, diseases and cellular functions. , 2004, Japanese journal of infectious diseases.
[4] F. Luft,et al. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. , 2004, Kidney international.
[5] A. Ben-Smith,et al. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation. , 2001, Blood.
[6] 星野 昭芳,et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification , 2008 .
[7] C. Kallenberg,et al. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies. , 2000, Journal of immunological methods.
[8] R. Coombs,et al. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. , 1992, The Journal of clinical investigation.
[9] Haruo Watanabe,et al. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. , 2002, Medical mycology.
[10] Haruo Watanabe,et al. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. , 2002, The Journal of infectious diseases.
[11] C. Kallenberg,et al. Neutrophil‐activating potential of antineutrophil cytoplasm autoantibodies , 2003, Journal of leukocyte biology.
[12] Radford,et al. The activation of the neutrophil respiratory burst by anti‐neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation , 1999, Clinical and experimental immunology.
[13] Kazuo Suzuki,et al. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan. , 2004, Japanese journal of infectious diseases.
[14] M. Bruchez,et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.
[15] Vincent Noireaux,et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.
[16] A. Bollen,et al. Human recombinant myeloperoxidase antiviral activity on cytomegalovirus , 2002, Journal of medical virology.
[17] Kazuo Suzuki,et al. Genetic Dissection of Vasculitis, Myeloperoxidase-Specific Antineutrophil Cytoplasmic Autoantibody Production, and Related Traits in Spontaneous Crescentic Glomerulonephritis-Forming/Kinjoh Mice1 , 2006, The Journal of Immunology.
[18] Kazuo Suzuki,et al. Contribution of Myeloperoxidase to Coronary Artery Vasculitis Associated with MPO-ANCA Production , 2001, Inflammation.
[19] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[20] K. Suzuki,et al. Modulation of chemotaxis, O(2)(-) production and myeloperoxidase release from human polymorphonuclear leukocytes by the ornithine-containing lipid and the serineglycine-containing lipid of Flavobacterium. , 2000, FEMS immunology and medical microbiology.
[21] P. Heeringa,et al. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? , 2005, Trends in immunology.
[22] Y. Adachi,et al. Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. , 2000, FEMS immunology and medical microbiology.
[23] B. Yard,et al. SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits. , 2003, Kidney international.
[24] R. Good,et al. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[25] Kazuo Suzuki,et al. Myeloperoxidase has Directly-opposed Effects on Nitration Reaction--Study on Myeloperoxidase-deficient Patient and Myeloperoxidase-knockout Mice , 2003, Free radical research.
[26] A. Busjahn,et al. Membrane expression of proteinase 3 is genetically determined. , 2003, Journal of the American Society of Nephrology : JASN.
[27] Kazuo Suzuki,et al. Induction of Coronary Arteritis with Administration of CAWS (Candida albicans Water‐Soluble Fraction) Depending on Mouse Strains , 2004, Immunopharmacology and immunotoxicology.
[28] C. Savage,et al. Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. , 2000, Arthritis and rheumatism.
[29] N. Ohno. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans. , 2004, Japanese journal of infectious diseases.
[30] T. Morita,et al. Mesangiolysis: an update. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[31] M. Steens,et al. Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase , 1992, FEBS letters.
[32] S. Nourshargh,et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. , 2005, Blood.
[33] Kazuo Suzuki,et al. Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] Kazuo Suzuki,et al. Contribution of myeloperoxidase in vasculitis development. , 2004, Japanese journal of infectious diseases.
[35] P. Cockwell,et al. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. , 2001, Kidney international.
[36] Hongjian Liu,et al. Western blot analysis with quantum dot fluorescence technology: a sensitive and quantitative method for multiplexed proteomics , 2005 .
[37] J. Grünfeld,et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations. , 1993, Journal of Autoimmunity.
[38] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[39] P. Heeringa,et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.
[40] S. Horie,et al. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. , 2003, Biological & pharmaceutical bulletin.
[41] Kazuo Suzuki. Neutrophil functions of patients with MPO-ANCA-related vasculitis. , 2003, Internal medicine.
[42] Kazuo Suzuki,et al. Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] K. Suzuki,et al. Nanocrystal Quantum Dot-Conjugated Anti-Myeloperoxidase Antibody as the Detector of Activated Neutrophils , 2007, IEEE Transactions on NanoBioscience.
[44] S. Mizuno,et al. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. , 2000, Clinical Nephrology.
[45] E. Csernok,et al. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects , 1993, Clinical and experimental immunology.
[46] H. Koyama,et al. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. , 2000, The Journal of infectious diseases.
[47] Masato Yasuhara,et al. Quantum Dots Targeted to the Assigned Organelle in Living Cells , 2004, Microbiology and immunology.
[48] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[49] E. Csernok. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. , 2003, Autoimmunity reviews.
[50] M. Drayson,et al. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. , 2001, Arthritis and rheumatism.
[51] M. Ernst,et al. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo , 1994, Clinical and experimental immunology.
[52] Hedi Mattoussi,et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.
[53] H. Okamura,et al. Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-β-glucan complex (CAWS) , 2007, Experimental and Molecular Pathology.